首页> 外文OA文献 >Screening of Chlamydia trachomatis urogenital infections among the male and female population of the Republic of Macedonia
【2h】

Screening of Chlamydia trachomatis urogenital infections among the male and female population of the Republic of Macedonia

机译:马其顿共和国男性和女性人群中沙眼衣原体泌尿生殖道感染的筛查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Noninvasive urine screening for Chlamydia trachomatis infections offers a valuable public health tool, that could be of vast importance in Chlamydia control programs. The goal was to determine the prevalence of C. trachomatis infections among a sexually active population, to define the epidemiological factors associated with it, and to develop potential selective screening strategies among asymptomatic individuals in the Republic of Macedonia, using a highly sensitive and specific DNA amplification method for C. trachomatis. A total of 1435 urine samples, divided into two main groups: asymptomatic individuals (n = 1210) and symptomatic patients (n = 225), were tested. Samples from the asymptomatic group were collected during routine screening programs, while the symptomatic group consisted of patients with symptoms of urogenital tract infection, attending sexually transmitted diseases (STD) clinics. The presence of C. trachomatis was determined using commercial AMPLICOR C. trachomatis Assay (Roche Diagnostic Systems, Inc., Branchburg, NJ, USA). The prevalence of C. trachomatis infections among different groups was: recruits 0%, soldiers 0.4%, policemen 3.5%, clerks 4.6%, pregnant women 4%, and students 4.4%. The average prevalence for both groups (asymptomatic and symptomatic) was 2.3%[95% confidence interval (CI): 1.5-3.1%]. The average prevalence for the asymptomatic group was 1.6% (95% CI: 0.8-2.4%), while the average prevalence for the symptomatic group was 6.2% (95% CI: 3.1-9.3%) which were significantly different (P = 0.00003). Testing first void urine specimens by AMPLICOR C. trachomatis assay is a highly sensitive and specific method for diagnosing C. trachomatis infections in men and women. This method provides health care workers and public health officials with a new molecular amplification assay that uses noninvasive urine specimens for population-based screening purposes. The prevalence of C. trachomatis was relatively low among asymptomatic individuals. However, selective screening strategies are highly recommended for testing the student population in the Republic of Macedonia. ududJournal of the European Academy of Dermatology and Venereology 08/2005; 19(4):427-30. • 2.69 Impact Factorududud
机译:沙眼衣原体感染的无创尿液筛查提供了一种宝贵的公共卫生工具,这在衣原体控制计划中可能非常重要。目的是确定马萨诸塞州性活跃人群中沙眼衣原体感染的患病率,确定与之相关的流行病学因素,并使用高度敏感和特异的DNA在马其顿共和国无症状个体中制定潜在的选择性筛查策略。沙眼衣原体的扩增方法。总共测试了1435份尿液样本,分为两个主要组:无症状个体(n = 1210)和有症状患者(n = 225)。无症状组的样本是在常规筛查程序中收集的,而有症状组则由有泌尿生殖道感染症状的患者组成,就诊于性传播疾病(STD)诊所。使用商业的AMPLICOR沙眼衣原体测定法(Roche Diagnostic Systems,Inc.,Branchburg,NJ,美国)确定沙眼衣原体的存在。不同人群中沙眼衣原体感染的患病率分别为:新兵0%,士兵0.4%,警察3.5%,文员4.6%,孕妇4%,学生4.4%。两组(无症状和有症状)的平均患病率为2.3%[95%置信区间(CI):1.5-3.1%]。无症状组的平均患病率为1.6%(95%CI:0.8-2.4%),而有症状组的平均患病率为6.2%(95%CI:3.1-9.3%),差异显着(P = 0.00003) )。通过AMPLICOR沙眼衣原体检测法检测第一个空尿标本是诊断男性和女性沙眼衣原体感染的高度灵敏和特异的方法。这种方法为医护人员和公共卫生官员提供了一种新的分子扩增测定法,该测定法使用无创尿液样本进行基于人群的筛查。无症状个体中沙眼衣原体的患病率相对较低。但是,强烈建议采用选择性筛选策略来测试马其顿共和国的学生人数。 ud ud欧洲皮肤病与性病学会杂志08/2005; 19(4):427-30。 •2.69影响因子 ud ud ud

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号